Published in Vox Sang on January 01, 1985
Lymphocytes from patients with primary biliary cirrhosis spontaneously secrete high levels of IgG3 in culture. Clin Exp Immunol (1988) 0.79
The analysis and quantification of a clonal B cell response in a hyperimmunized anti-D donor. Clin Exp Immunol (2006) 0.75
Oral administration of erythrocyte membrane antigen does not suppress anti-Rh(D) antibody responses in humans. Clin Exp Immunol (1987) 0.75
Single cell assay of a transcription factor reveals a threshold in transcription activated by signals emanating from the T-cell antigen receptor. Genes Dev (1990) 3.98
Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc Natl Acad Sci U S A (1990) 3.70
Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis (1989) 3.67
The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J Biol Chem (2000) 3.24
Separation of normal and immune lymphoid cells by antigen-coated coated columns. Antigen-binding characteristics of membrane antibodies as analyzed by hapten-protein antigens. J Exp Med (1970) 3.08
A randomized, controlled trial of tonsillectomy in periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome. J Pediatr (2007) 2.82
Effect of the number of haptens coupled to each erythrocyte on haemolytic plaque formation. Immunology (1969) 2.71
The role of cell number and source in adoptive immunity. Immunology (1965) 2.68
The effect of antigen dosage on the response of adoptively transferred cells. Immunology (1965) 2.59
Inherited immunoglobulin idiotypes of the mouse. Immunol Rev (1977) 2.29
Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation. Infect Immun (2001) 2.03
Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases. J Clin Pathol (1984) 1.98
Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer. Br J Cancer (1986) 1.91
Soluble antigen-antibody complexes and platelet aggregation. Acta Pathol Microbiol Scand (1969) 1.91
Inheritance of antibody specificity. I. Anti-(4-hydroxy-3-nitrophenyl)acetyl of the mouse primary response. J Exp Med (1974) 1.82
Strain differences in the fine specificity of mouse anti-hapten antibodies. Eur J Immunol (1973) 1.69
Isolated hapten-binding receptors of sensitized lymphocytes. I. Receptors from nylon wool-enriched mouse T lymphocytes lack serological markers of immunoglobulin constant domains but express heavy chain variable portions. Eur J Immunol (1977) 1.61
Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis. J Exp Med (1992) 1.56
Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. Br J Cancer (1984) 1.56
The diversity and specialization of immunocytes. Prog Allergy (1970) 1.54
Anti-oxazolone hybridomas and the structure of the oxazolone idiotype. J Immunol (1983) 1.52
Improving meat cutters' work: changes and effects following an intervention. Appl Ergon (2013) 1.48
Assay of anti-hapten antibody with the aid of hapten-coupled bacteriophage. Immunology (1966) 1.48
Studies on renal function in burns. II. Early signs of impaired renal function in lethal burns. Acta Chir Scand (1970) 1.39
The four subclasses of IgG can be isolated from mouse serum by using Protein A-Sepharose. Scand J Immunol (1981) 1.37
Determination of 19S and 7S components in an anti-hapten antibody. Ann Med Exp Biol Fenn (1967) 1.34
Affinity requirements for antibody assays mapped by monoclonal antibodies. J Immunol (1983) 1.33
Analogies between lymphocyte receptors and the resulting humoral antibodies. Transplant Rev (1970) 1.29
A mendelian idiotype is demonstrable in the heteroclitic anti-NP antibodies of the mouse. Eur J Immunol (1978) 1.29
Single lymph node cells producing heteroclitic bacteriophage antibody. J Immunol (1965) 1.28
IgG subclasses of pneumococcal antibodies--effect of allotype G2m(n). Scand J Immunol (1989) 1.26
The percentages of six immunoglobulin isotypes in human antibodies to tetanus toxoid: standardization of isotype-specific second antibodies in solid-phase assay. Eur J Immunol (1984) 1.25
Cellular heterogeneity in the production of an anti-hapten antibody. J Exp Med (1967) 1.22
Negative regulation of interleukin 2 transcription by the glucocorticoid receptor. J Exp Med (1992) 1.21
Renal artery stenosis and the nephrotic syndrome. Acta Med Scand (1967) 1.17
Immunogenic properties of alpha (1----6) dextran, its protein conjugates, and conjugates of its breakdown products in mice. Scand J Immunol (1984) 1.17
The expanding clinical spectrum of ocular lyme borreliosis. Ophthalmology (2000) 1.15
Haptenated bacteriophage in the assay of antibody quantity and affinity: maturation of an immune response. Immunochemistry (1970) 1.14
Isotype concentrations of human antibodies to group A meningococcal polysaccharide. J Immunol (1986) 1.12
Human antibody responses to two conjugate vaccines of Haemophilus influenzae type B saccharides and diphtheria toxin. Scand J Immunol (1988) 1.11
Effect of the number of primed cells on the production of IgM and IgG antibodies in an adoptive secondary response. Int Arch Allergy Appl Immunol (1968) 1.11
Antigenicity of dextran-protein conjugates in mice. Effect of molecular weight of the carbohydrate and comparison of two modes of coupling. J Immunol (1989) 1.11
IgG subclass distributions in anti-hapten and anti-polysaccharide antibodies induced by haptenated polysaccharides. Eur J Immunol (1983) 1.10
Proportions of Ig classes and subclasses in rubella antibodies. Scand J Immunol (1985) 1.10
Genetics of mouse antibodies. II. Recombination between VH genes and allotype. Eur J Immunol (1975) 1.10
Quantitation of human IgG subclass antibodies to Haemophilus influenzae type b capsular polysaccharide. Results of an international collaborative study using enzyme immunoassay methodology. J Immunol Methods (1992) 1.09
Lack of heterogeneity in antihapten antibodies of a phylogenetically primitive shark. Nature (1980) 1.07
Selective inhibition of the secondary response of primed cells by incubation with hapten. Immunology (1968) 1.06
Anti-hapten antibodies in normal sera. Eur J Immunol (1971) 1.06
Rifaximin in the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther (2012) 1.02
Salmonella antigen 12-2: genetics of form variation. Ann Med Exp Biol Fenn (1966) 1.02
Characterization of a spontaneous disease of white leghorn chickens resembling progressive systemic sclerosis (scleroderma). J Exp Med (1981) 1.00
Inheritance of antibody specificity. IV. Control of related molecular species by one VH gene. Cold Spring Harb Symp Quant Biol (1977) 1.00
Concentrations of three hapten-binding immunoglobulins in pooled normal human serum. Eur J Immunol (1976) 0.99
High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment. Bone Marrow Transplant (2003) 0.99
Antibody responses in arthritic and uncomplicated Yersinia enterocolitica infections. J Clin Immunol (1985) 0.98
Affinity of IgM and IgG antibodies. Immunochemistry (1970) 0.98
Establishment of anti-TNP antibody-producing human lymphoid lines by preselection for hapten binding followed by EBV transformation. Scand J Immunol (1979) 0.98
Feasibility of commercial interferon-gamma-based methods for the diagnosis of latent Mycobacterium tuberculosis infection in Finland, a country of low incidence and high bacille Calmette-Guérin vaccination coverage. Clin Microbiol Infect (2007) 0.98
Standard sera in solid-phase immunoassays. Eur J Immunol (1983) 0.97
Modification of bacteriophage with hapten-epsilon-aminocaproyl-N-hydroxysuccinimide esters; increased sensitivity for immunoassay. Immunochemistry (1975) 0.97
Rh prevention: a report and analysis of a national programme. J Med Genet (1973) 0.97
Extensive allelic sequence variation in the J region of the human immunoglobulin heavy chain gene locus. Eur J Immunol (1995) 0.96
Immunological cross-reactions within a family of related haptens. Immunochemistry (1972) 0.96
MAR, a novel high-incidence Rh antigen revealing the existence of an allelic sub-system including Cw (Rh8) and Cx (Rh9) with exceptional distribution in the Finnish population. Vox Sang (1994) 0.96
Isotype distribution and bactericidal activity of antibodies after immunization with Haemophilus influenzae type b vaccines at 18-24 months of age. J Infect Dis (1988) 0.96
Establishment of specific antibody producing human lines by antigen preselection and Epstein-Barr virus (EBV)-transformation. J Clin Lab Immunol (1979) 0.95
Mouse Ig coded by VH families S107 or J606 bind to protein A. J Immunol (1990) 0.94
Suppression or augmentation of the antihapten response in mice by antibodies of different specificities. J Exp Med (1973) 0.94
Female Baltic herring Clupea harengus allocate resources from growth to reproduction in poor feeding conditions. J Fish Biol (2015) 0.94
Isotypes of antibodies induced by plain dextran or a dextran-protein conjugate. Eur J Immunol (1985) 0.94
Adjuvant effect of bacterial LPS and/or alum precipitation in responses to polysaccharide and protein antigens. Immunology (1984) 0.92
Half-life of the maternal IgG1 allotype in infants. J Clin Immunol (1993) 0.92
Allotype-associated differences in concentrations of human IgG subclasses. J Clin Immunol (1991) 0.92
TNF alpha-induced expression of endothelial adhesion molecules, ICAM-1 and VCAM-1, is linked to protein kinase C activation. Scand J Immunol (1992) 0.91
Maternal antibodies partly inhibit an active antibody response to routine tetanus toxoid immunization in infants. J Infect Dis (1992) 0.91
[Prevention of RH immunization in Finland. Result of a 2-year nationwide anti-D program in Finland]. Nord Med (1971) 0.91
The range and fine specificity of the anti-hapten immune response: phylogenetic studies. J Immunogenet (1982) 0.90
Specifically cytotoxic human and mouse lymphoid cells induced with antibody or antigen-antibody complexes. J Immunol (1975) 0.90
Carrier preimmunisation in the anti-hapten response of a marine fish. Nature (1975) 0.90
Failure to demonstrate public idiotypes on cytolytic cells with specificity for NP-coupled syngeneic cells. Scand J Immunol (1980) 0.89
Differential induction of membrane-associated interleukin 1 (IL-1) expression and IL-1 alpha and IL-1 beta secretion by lipopolysaccharide and silica in human monocytes. Scand J Immunol (1988) 0.89
Subtypes of human ABO blood groups and subtype-specific antibodies. J Immunol (1969) 0.89
Familial occurrence of abdominal aortic aneurysm. Ann Intern Med (1999) 0.89
Antibody affinity in mice with the CBA/N defect. J Immunol (1980) 0.89
Oligomeric IgA: the major component of the in vitro primary response of mouse spleen fragments. J Exp Med (1973) 0.89
The protective capacity of immune sera in experimental mouse salmonellosis is mainly due to IgM antibodies. Immunol Lett (1982) 0.89
Immunoglobulin G subclass antibody responses in influenza A and parainfluenza type 1 virus infections. Clin Exp Immunol (1985) 0.89
Functional analogues of the VKOx1 gene in different strains of mice: evolutionary conservation but diversity based on V-J joining. J Immunol (1987) 0.88
Mouse IgG antibodies have subclass associated affinity differences. Mol Immunol (1983) 0.87
Several V genes participate in the early phenyloxazolone response in various combinations. Eur J Immunol (1986) 0.87
'Allelic' forms of immunoglobulin V genes in different strains of mice. EMBO J (1989) 0.86